Company Data

Beam Therapeutics Inc.

Ticker
BEAM
Current Price
$30.43 -8.18%
Market Cap
$2.5B
Price Target
Refer to Report
Volume
1.9M
52wk Range
$20.84 - $49.5
Advanced Market Data

Overview

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company’s portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy